Pfizer COVID-19 vaccines gets approval for emergency use among children in Nepal

KATHMANDU, September 12: The Pfizer COVID-19 vaccine has been granted approval for emergency use against the novel coronavirus disease (COVID-19) in Nepal.

The Department of Drugs Administrations (DDA) has granted the approval to administer Pfizer COVID-19 vaccines among childrens in Nepal.

“The DDA has granted permission to distribute Pfizer COVID-19 vaccines through the Ministry of Health and Population (MoHP),” said Narayan Prasad Dhakal, Director General of the department. “The government can now procure the Pfizer COVID-19 vaccines and administer it among childrens.”

The government has begun preparations to administer Pfizer COVID-19 vaccines to children who are more than 12 years old.

Nepal is scheduled to receive 100,000 doses of Pfizer COVID-19 vaccines in a few days through the COVAX facility.

So far, along with the Pfizer COVID-19 vaccine, Covishield, Vero Cell, J & J and Astrazeneca vaccines have been given approval for emergency use against COVID-19. (With inputs from Annapurna Post)